Back to list

Prescription only

ALIENSIDIPINE

Generic Name
Enasidenib
Specification
50mg × 30 ເມັດ
Dosage Form
—
FDD Registration No.
11-LM-01273-24
Valid until
2028-09-28

Prescription only — Information only — no online sales

Description

Ingredients
Enasidenib mesylate 50mg
Indications
IDH2-mutated relapsed/refractory acute myeloid leukemia (AML)
Dosage & Administration
Oral administration
Description
ALIENSIDIPINE, active ingredient enasidenib mesylate, tablet, registered in Lao PDR.

Related products

Aliivosidenib
Prescription only

Aliivosidenib

Generic Name:Ivosidenib

Specification:250mg × 60 ເມັດ

Oncology & Hematology

View Details
ALIOLAPARIB
Prescription only

ALIOLAPARIB

Generic Name:Olaparib

Specification:150mg × 120 ເມັດ

Oncology & Hematology

View Details
Osimitib
Prescription only

Osimitib

Generic Name:Osimertinib

Specification:80mg × 30 ເມັດ

Oncology & Hematology

View Details
ALIDABRAFENIB
Prescription only

ALIDABRAFENIB

Generic Name:Dabrafenib

Specification:75mg × 120 ແຄບຊູນ

Oncology & Hematology

View Details
Information only — no online salesDisclaimer & Terms02057111655

Information only — no online sales · Disclaimer & Terms